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A Ab bs st tr ra ac ct t
Three recent papers have identified distinct enzymes that can remove ubiquitin from mammalian
histone 2A (H2A). Functions in transcriptional activation, DNA repair and control of the cell
cycle have been proposed for these enzymes.
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Ubiquitination is a reversible posttranslational modification
of proteins that could rival phosphorylation in its scope
and complexity. Removal of ubiquitin is accomplished
through the action of deubiquitinating enzymes (DUBs),
which fall into five distinct families in the human genome,
containing about 84 active members [1,2]. Post-
translational modifications of histones include methy-
lation, acetylation, sumoylation and ubiquitination,
enabling a combinatorial code to regulate chromatin
structure [3] and recruit protein complexes [4]. An
example of the interplay between these modifications is
provided by the activity of Ubp8, a yeast deubiquitinating
enzyme which regulates the methylation of histone 3 (H3)
on lysine 4 (K4 methylation) by deubiquitinating
histone 2B (H2B) [5]. About 5-15% of histone 2A (H2A)
is monoubiquitinated in mammalian cells, making it
the most abundant ubiquitinated protein in the
nucleus; in fact, it was the first example of a
ubiquitinated protein to be described [6]. Mono-
ubiquitination is not linked to protein degradation,
but instead plays a role in transcriptional control, DNA
repair and other processes. It has also long been known
that deubiquitination of histones occurs during
metaphase of the cell cycle, coincident with complete
condensation of the chromosomes [7,8]. Mono-
ubiquitination of H2A has been linked to Polycomb
group complex-dependent gene silencing [9] and
X-chromosome inactivation [10]. Furthermore, DNA
damage induces mono-ubiquitination of H2A in the
vicinity of DNA lesions after incision of the damaged
strand [11].
I Id de en nt ti if fi ic ca at ti io on n   o of f   H H2 2A A- -d de eu ub bi iq qu ui it ti in na at ti in ng g   e en nz zy ym me es s
Three recent papers identify distinct DUBs with activity
towards H2A and begin to unravel their cellular functions
(Figure 1). Zhu et al. [12] identified MYSM1/KIAA1915
(belonging to the JAMM/MPN+ family of metalloprotease
DUBs [13]) in a screen for factors regulating androgen-
controlled gene expression. The authors argue that MYSM1
is an H2A-specific DUB on the basis of decreased ubiquitina-
tion following overexpression of MYSM1 in HEK293T
human embryonic kidney cells and the accumulation of ubi-
quitinated H2A (Ub-H2A) following knockdown of MYSM1.
The ubiquitin-specific proteases (USPs) comprise the largest
family of cysteine protease DUBs. Two members of this
family are now proposed to act on H2A. Nicassio et al. [14]
have taken chromatin-enriched fractions through affinity
purification on ubiquitin-agarose. Analysis of the resultant
gel bands by mass spectrometry identified USP3 and USP5/
isopeptidase T. USP3 is the human DUB most homologous
to  Saccharomyces cerevisiae Ubp8, which has previously
been shown to promote H2B deubiquitination [15]. Over-
expression of USP3 in HeLa cells reduced levels of both
Ub-H2A and Ub-H2B, whereas knockdown of USP3 enhanced
the ubiquitination of both histones.
In another recent study, Joo et al. [16] have undertaken
an epic purification of DUB activity from HeLa nuclear
fractions using an in vitro assay of H2A deubiquitination
with mononucleosomes as substrate. A silver-stained
band identified as USP16/Ubp-M could be correlated with
deubiquitinating activity through a six-column purificationprocedure. Immunodepletion of USP16 from a purified
fraction also depleted H2A-DUB activity. Previous work had
already shown that overexpression of USP16/Ubp-M in 293
cells leads to H2A deubiquitination [17]. Joo et al. [16] now
show that small interfering RNA-mediated knockdown of
USP16 in HeLa cells leads to the predicted accumulation of
Ub-H2A, but in distinction to USP3, no accumulation of
Ub-H2B was found on USP16 knockdown. Interestingly,
USP16 showed enhanced in vitro activity against Ub-H2A
incorporated into oligonucleosomes and could not act upon
Ub-H2A in isolation [16]. Taken together, the data indicate
that USP16 is a nucleosomal H2A-specific DUB.
M MY YS SM M1 1   a an nd d   U US SP P1 16 6   a ac ct ti iv va at te e   t tr ra an ns sc cr ri ip pt ti io on n
Co-immunoprecipitation and peptide mass fingerprinting
identified the histone acetylase p300/CBP-associated factor
(PCAF) as a MYSM1 binding partner [12]. Subsequent experi-
mental evidence uncovered no cross-talk with histone
methylation, but led the authors to propose an interesting
model whereby PCAF-dependent acetylation of nucleosomal
components precedes MYSM1 deubiquitination of H2A. In
turn, this deubiquitination may promote histone 1 (H1)
phosphorylation, a trigger for H1 dissociation from nucleo-
somes that is often linked with gene activation. Zhu et al.
[12] provide a clear illustration of this effect, by showing that
expression of androgen receptor target genes following
dihydrotestosterone (DHT)-induced activation in LNCaP
prostate cancer cells is significantly impaired by MYSM1
knockdown. Accordingly, chromatin immunoprecipitation
(ChIP) analysis indicated that MYSM1 and PCAF are
enriched on the promoter region of the gene for prostate-
specific antigen (PSA) gene following DHT treatment. MYSM1
is also enriched at exonic regions of the gene, suggesting a
potential role in transcript elongation as well as initiation.
Control of the H2A ubiquitination status has been linked to
HOX gene silencing [9,18], leading Joo et al. [16] to examine
a role for USP16 in HOX gene expression. They show that
HOXD10 transcription is reduced following USP16 knock-
down, in a manner that can be rescued by transfection with
wild-type enzyme. ChIP analysis revealed binding sites for
USP16 within the 5’ promoter but not the coding region of
HOXD10, which accumulate Ub-H2A following USP16 knock-
down. A nice demonstration of the physiological significance
of this finding is derived from injection of anti-USP16 into
two-cell-stage  Xenopus embryos, which leads to reduced
Hoxd10 expression and defects in anterior-posterior
patterning [16]. Thus both MYSM1 and USP16 can positively
regulate the expression of certain genes. This is consistent
with their specificity for Ub-H2A, which is thought to be
transcriptionally repressive, rather than human Ub-H2B,
which activates HOX gene expression [19].
U US SP P3 3   a an nd d   U US SP P1 16 6   a ar re e   r re eq qu ui ir re ed d   f fo or r   c ce el ll l- -c cy yc cl le e
p pr ro og gr re es ss si io on n
Functional studies suggest roles for both USP3 and USP16 in
the control of the cell cycle. Earlier work had shown that
USP16 is phosphorylated at the onset of mitosis and dephos-
phorylated during the metaphase-anaphase transition.
Furthermore, USP16 tagged with green fluorescent protein
generally presents a cytosolic distribution, but a catalytically
inactive form associates with mitotic chromosomes at all
stages of cell division and remains nuclear in interphase cells
[20]. Joo et al. [16] show that USP16 knockdown reduces the
number of cells in M phase. In synchronized control cells,
Ub-H2A levels decrease during M phase and recover to
normal levels when cells reach G1/S. In USP16 knockdown
cells the reduction in Ub-H2A is much less pronounced and
entry into mitosis is delayed. Fluctuations in Ub-H2A levels
inversely correlate with phospho-H3 levels. Using recon-
stituted mononuclesomes, Joo et al. [16] could show that the
presence of Ub-H2A is inhibitory to Aurora B kinase-
mediated phosphorylation of H3 on serine 10 (S10), and that
this activity can be restored by treatment with USP16. Thus,
H2A deubiquitination may be a prerequisite for H3-S10
phosphorylation; the authors suggest that this is likely to be
due to occlusion of the Aurora B binding site by ubiquitin.
Nicassio et al. [14] found that following knockdown of USP3
in an osteosarcoma cell line (U2OS), release from a thymi-
dine block leads to slower progression through S phase and
delayed entry into mitosis, as judged by fluorescence-
activated cell sorting (FACS) analysis and incorporation of
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Common and distinct functional outputs of three enzymes that
deubiquitinate H2A. These three enzymes - MYSMI, USP16 and USP3 -
have been proposed to remove ubiquitin from Ub-H2A. MYSMI and
USP16 share a common role in transcriptional control of potentially
distinct gene cohorts, whereas USP16 and USP3 DUB activities have been
implicated in cell-cycle progression. USP3 may indirectly influence cycling
of cells through effects on DNA damage repair pathways.





USP16 MYSM1bromodeoxyuridine into DNA. As seen with USP16 knock-
down, H3 phosphorylation is delayed. One possible cause of
the cell-cycle defects, highlighted by the authors, might be
DNA damage leading to the activation of checkpoint
controls. They could detect an early signature of this
response in USP3-silenced U2OS cells by visualizing the
accumulation of phosphorylated H2AX (γ-H2AX) and the
checkpoint protein 53BP1 in nuclear foci, together with
positive assays for the occurrence of single-strand DNA
breaks. Further experiments, monitoring the ability of cells
to recover from ionizing-radiation-induced DNA damage,
revealed a marked delay in the dissipation of γ-H2AX- and
Ub-H2A-positive foci compared with control cells [14].
Other DUBs have also recently been implicated in cell-
cycle control. A screen for novel cell-cycle regulators in
human cells (using knockdown by short hairpin RNAs)
identified USP44 as a critical regulator of the spindle
checkpoint, through stabilization of the Mad2-CDC20
complex, which inhibits the anaphase-promoting complex
(APC) [21], a ubiquitin ligase that targets certain cell-cycle
proteins for destruction. This visual screen containing 63
DUBs (including USP3 and USP16) scored the mitotic
index following a 24-hour incubation with taxol. It also
identified USP24 as a candidate DUB involved in
checkpoint control and CYLD as a pre-mitotic cell-cycle
regulator. Subsequent studies of CYLD have suggested that
it may act in mitosis by controlling the ubiquitination
status of the Polo-like kinase Plk1 [22].
C Ch hr ro om ma at ti in n   b bi in nd di in ng g
MYSM1 is the only DUB in the genome with recognizable
chromatin-binding domains, containing both the SWIRM
(Swi3p, Rsc8p and Moira) [23] and SANT (SWI-SNF, ADA
N-CoR, TFIIIB)/Myb domains [24]. The SANT, but not the
SWIRM, domain of MYSM1 can bind directly to DNA [25].
Intriguingly USP3, USP16 and USP44 all possess a zinc-
finger domain, ZnF UBP, amino-terminal to their catalytic
domain. Several proteins with this motif (for example,
USP5/isopeptidase T and HDAC6) have been shown to bind
ubiquitin, but in the case of USP5 this requires an unconju-
gated ubiquitin carboxy-terminal diglycine motif, suggesting
that it may primarily process free ubiquitin chains [26] or
act as a sensor of free ubiquitin levels. Characterization of
the ZnF UBP domain by nuclear magnetic resonance
suggests that the same holds true for USP16, despite
structural differences from USP5 in the pattern of zinc
coordination [27]. An intact ZnF UBP domain is necessary
for USP3 association with H2A, as judged by co-immuno-
precipitation, but the requirement for ubiquitination is un-
clear [14]. If the ZnF UBP domain cannot recognize
conjugated ubiquitin, then on the basis of the functional
studies described above it seems plausible that it might
represent a novel recognition motif for as-yet-unidentified
chromatin-associated factors.
Three DUBs have now been shown to have profound effects
on global Ub-H2A levels (Figure 2). What can this signify?
One possibility is that each DUB targets a distinct pool of
Ub-H2A. For example, one could propose that USP3 might
specifically target the pool of Ub-H2A that accumulates at
DNA repair foci, or that MYSM1 and USP16 are recruited to
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F Fi ig gu ur re e   2 2
Proposed models for the role of three H2A-DUBs - MYSM1, USP16 and
USP3 - in regulating reversible modifications of histones. ( (a a) ) Histone
acetylation by PCAF (1) is proposed to promote removal of ubiquitin
from lysine 119 (K119) in the H2A tail by associated MYSM1 (2). This
promotes phosphorylation of H1 and its consequent dissociation from
chromatin (3), facilitating transcriptional initiation and elongation of
androgen receptor-regulated genes (4). ( (b b) ) Deubiquitination of Ub-H2A
by USP16 (1) leads to phosphorylation of H3 at serine 10 (S10) by the
kinase Aurora B and subsequent G2/M cell-cycle progression (2). It also
promotes transcriptional initiation of HOX gene transcription (3). ( (c c) )
USP3 can remove ubiquitin from both H2A K119 and H2B K120 (1),
promoting dephosphorylation of the H2AX variant histone and
concomitant recovery from the ATM/ATR DNA-damage checkpoint
during DNA repair (2). USP3 activity may also promote phosphorylation
of H3 at S10, which is associated with entry into M phase (3). (a) adapted
from Zhu et al. [12].different cohorts of gene promoters. However, the magni-
tude of changes in the ubiquitinated fraction of H2A seen for
each DUB following overexpression or knockdown suggests
that the pool accessible to each DUB must be a significant
fraction of total H2A. It is currently not known if these effects
are additive. Nor at this point can it be definitively concluded
that each enzyme directly deubiquitinates Ub-H2A in vivo.
Thus, an alternative possibility is that the action of one may
be contingent on that of another, through regulation of
stability or activity. Other DUBs may yet join this trio, as no
systematic screen for DUBs regulating Ub-H2A levels has so
far been reported. In fact, while this review was being
prepared for publication, Nakagawa et al. [28] reported a
role for USP21 in deubiquitinating H2A, resulting in
transcriptional activation.
A Ac ck kn no ow wl le ed dg ge em me en nt ts s
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